Incidence of Extrusion Following Type I Polypropylene Mesh “Kit” Repairs in the Correction of Pelvic Organ Prolapse

Table 1

Subject demographics.

	AC mesh, 𝑁=173			PC/A mesh, 𝑁=195
Baseline characteristic	Extrusion 𝑁=13	No extrusion 𝑁=160	𝑃 value	Extrusion 𝑁=27	No extrusion 𝑁=168	𝑃 value
Age*	58.6±10.4,	60.8±12.8,	0.48^W	56.3±15.3,	58.7±12.2,	0.37^W
BMI	25.4±3.7,	27.8±5.9,	0.21^W	28.2±7.9,	28.6±5.6,	0.42^W
Parity	3±2,	3±2,	0.53^W	3±1,	3±2,	0.28^W
Prior failed prolapse procedure: Cystocele*	4 (30.8%)	25 (15.6%)	0.24^F	—	—	—
Prior failed prolapse procedure: Rectocele*	—	—	—	3 (11.1%)	9 (5.4%)	0.22^F
Prior failed prolapse procedure: apical*	—	—	—	2 (7.4%)	7 (4.2%)	0.36^F
Prior hysterectomy*	12 (92.3%)	74 (46.3%)	0.00^C	13 (48.1%)	84 (50.0%)	0.86^C
Postmenopausal	13 (100%)	125 (78.1%)	0.07^F	20 (74.1%)	126 (75.0%)	0.92^C
Estrogen therapy at baseline	9 (69.2%)	72 (45.0%)	0.09^C	15 (55.6%)	87 (51.8%)	0.72^C
Diabetic	1 (7.7%)	13 (8.1%)	1.00^F	3 (11.1%)	17 (10.1%)	1.00^F
Moderate to severe vaginal atrophy at baseline (based on pH)*	3 (23.1%)	39 (24.4%)	1.00^F	6 (22.2%)	33 (19.6%)	0.77^C

*Covariates assessed for the risk of an extrusion.
^WWilcoxon rank sum test; ^Cchi-square test; ^FFisher exact test.
AC: anterior compartment; PC/A: posterior compartment/apex; BMI: body mass index.